Cargando…

Transcriptome analysis following enterovirus 71 and coxsackievirus A16 infection in respiratory epithelial cells

Enterovirus 71 (EV-A71) and coxsackievirus A16 (CV-A16) are the major pathogens responsible for hand, foot and mouth disease (HFMD), but the mechanism by which these viruses cause disease remains unclear. In this study, we used transcriptome sequencing technology to investigate changes in the transc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Jie, Hu, Yajie, Li, Weiyu, Li, Hui, Zheng, Huiwen, Chen, Yanli, Dong, Shaozhong, Liu, Longding
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522011/ https://www.ncbi.nlm.nih.gov/pubmed/32990841 http://dx.doi.org/10.1007/s00705-020-04821-1

Ejemplares similares

microRNA-4516 Contributes to Different Functions of Epithelial Permeability Barrier by Targeting Poliovirus Receptor Related Protein 1 in Enterovirus 71 and Coxsackievirus A16 Infections
por: Hu, Yajie, et al.
Publicado: (2018)

Suppression of the toll-like receptor 7-dependent type I interferon production pathway by autophagy resulting from enterovirus 71 and coxsackievirus A16 infections facilitates their replication
por: Song, Jie, et al.
Publicado: (2017)

A hSCARB2-transgenic mouse model for Coxsackievirus A16 pathogenesis
por: Chen, Yanli, et al.
Publicado: (2021)

Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China
por: Ji, Hong, et al.
Publicado: (2012)

Immunologic Characterization of Cytokine Responses to Enterovirus 71 and Coxsackievirus A16 Infection in Children
por: Zhang, Shu-Yan, et al.
Publicado: (2015)

Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China
por: Li, Wei, et al.
Publicado: (2013)

VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment
por: Chen, Fang-Hong, et al.
Publicado: (2019)

Bioinformatics-based prediction of conformational epitopes for Enterovirus A71 and Coxsackievirus A16
por: Wang, Liping, et al.
Publicado: (2021)

Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010
por: Ang, Li Wei, et al.
Publicado: (2015)

Seroprevalence of Enterovirus A71 and Coxsackievirus A16 in Healthy People in Shandong Province, China
por: Wang, Jian-xing, et al.
Publicado: (2016)

Detection of human enterovirus 71 and coxsackievirus A16 in children with hand, foot and mouth disease in China
por: CHEN, LING, et al.
Publicado: (2012)

Novel Substituted Heteroaromatic Piperazine and Piperidine Derivatives as Inhibitors of Human Enterovirus 71 and Coxsackievirus A16
por: Zhang, Xian, et al.
Publicado: (2013)

Antiviral Ability of Kalanchoe gracilis Leaf Extract against Enterovirus 71 and Coxsackievirus A16
por: Wang, Ching-Ying, et al.
Publicado: (2012)

Computational Screening of Newly Designed Compounds against Coxsackievirus A16 and Enterovirus A71
por: Sripattaraphan, Amita, et al.
Publicado: (2022)

Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: Improved primers for the specific detection of human enterovirus 71 by RT PCR
por: Perera, David, et al.
Publicado: (2004)

Seroprevalence of Human Enterovirus 71 and Coxsackievirus A16 in Guangdong, China, in Pre- and Post-2010 HFMD Epidemic Period
por: Li, Wei, et al.
Publicado: (2013)

Systematic Identification and Bioinformatic Analysis of MicroRNAs in Response to Infections of Coxsackievirus A16 and Enterovirus 71
por: Zhu, Zheng, et al.
Publicado: (2016)

A Bivalent Inactivated Vaccine Prevents Enterovirus 71 and Coxsackievirus A16 Infections in the Mongolian Gerbil
por: Yi, Eun-Je, et al.
Publicado: (2023)

Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice
por: Zhao, Hui, et al.
Publicado: (2015)

Comparing Enterovirus 71 with Coxsackievirus A16 by analyzing nucleotide sequences and antigenicity of recombinant proteins of VP1s and VP4s
por: Li, Yuyun, et al.
Publicado: (2011)

Human enterovirus 71 subgenotype B3 lacks coxsackievirus A16-like neurovirulence in mice infection
por: Chan, Yoke-Fun, et al.
Publicado: (2005)

Identification of Luteolin as Enterovirus 71 and Coxsackievirus A16 Inhibitors through Reporter Viruses and Cell Viability-Based Screening
por: Xu, Lin, et al.
Publicado: (2014)

Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease
por: Wang, Jingjing, et al.
Publicado: (2013)

Serum MicroRNA Expression Profile Distinguishes Enterovirus 71 and Coxsackievirus 16 Infections in Patients with Hand-Foot-and-Mouth Disease
por: Cui, Lunbiao, et al.
Publicado: (2011)

Evaluation of human enterovirus 71 and coxsackievirus A16 specific immunoglobulin M antibodies for diagnosis of hand-foot-and-mouth disease
por: Yu, Nan, et al.
Publicado: (2012)

Development of a multiplex polymerase chain reaction assay for simultaneous identification of human enterovirus 71 and coxsackievirus A16
por: Thao, Nguyen Thi Thanh, et al.
Publicado: (2010)

Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16
por: Kelly, James T., et al.
Publicado: (2015)

Development of stable, cold-adapted, temperature-sensitive/conditional lethal chimeric enterovirus A71 and coxsackievirus A16
por: Chua, Kaw Bing, et al.
Publicado: (2022)

Molecular evolutionary dynamics of enterovirus A71, coxsackievirus A16 and coxsackievirus A6 causing hand, foot and mouth disease in Thailand, 2000–2022
por: Noisumdaeng, Pirom, et al.
Publicado: (2023)

Estimation of Basic Reproduction Number of Enterovirus 71, Coxsackievirus A6 and A16 in Hand, Foot, and Mouth Disease Outbreaks in Singapore
por: Lim, Cindy, et al.
Publicado: (2014)

Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71
por: Tan, Xiu Hui, et al.
Publicado: (2023)

Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China
por: Cai, Kang, et al.
Publicado: (2019)

Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand
por: Lerdsamran, Hatairat, et al.
Publicado: (2018)

Applicability of duplex real time and lateral flow strip reverse-transcription recombinase aided amplification assays for the detection of Enterovirus 71 and Coxsackievirus A16
por: Li, Xin-na, et al.
Publicado: (2019)

Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3
por: Song, Jae-Hyoung, et al.
Publicado: (2014)

Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017
por: Kamau, Everlyn, et al.
Publicado: (2021)

Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice
por: Caine, Elizabeth A., et al.
Publicado: (2015)

Complete genome analysis demonstrates multiple introductions of enterovirus 71 and coxsackievirus A16 recombinant strains into Thailand during the past decade
por: Noisumdaeng, Pirom, et al.
Publicado: (2018)

Co-Circulation and Genomic Recombination of Coxsackievirus A16 and Enterovirus 71 during a Large Outbreak of Hand, Foot, and Mouth Disease in Central China
por: Liu, Weiyong, et al.
Publicado: (2014)

Pyroptosis induced by enterovirus 71 and coxsackievirus B3 infection affects viral replication and host response
por: Wang, Yan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_10ck0mch477sqoq3auc8kth66n